HealthEquity Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for HealthEquity stock have an average target of 111.23, with a low estimate of 100 and a high estimate of 130. The average target predicts an increase of 16.25% from the current stock price of 95.68.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$100	$111.23	$108	$130
Change	+4.52%	+16.25%	+12.88%	+35.87%

Analyst Ratings

The average analyst rating for HealthEquity stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	3	3	3	3	3	3
Buy	8	8	8	8	8	9
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides JMP Securities	JMP Securities	Buy Maintains $105 → $107	Buy	Maintains	$105 → $107	+11.83%	Dec 10, 2024
Sean Dodge RBC Capital	RBC Capital	Buy Maintains $100 → $105	Buy	Maintains	$100 → $105	+9.74%	Dec 10, 2024
Steven Valiquette Mizuho	Mizuho	Buy Initiates $126	Buy	Initiates	$126	+31.69%	Dec 4, 2024
Alexander Paris Barrington Research	Barrington Research	Buy Maintains $105 → $120	Buy	Maintains	$105 → $120	+25.42%	Dec 2, 2024
David Roman Goldman Sachs	Goldman Sachs	Hold Initiates $108	Hold	Initiates	$108	+12.88%	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.20B

from 999.59M

20.25%

from 999.59M

Revenue Next Year

1.32B

from 1.20B

9.73%

from 1.20B

EPS This Year

3.16

from 0.64

394.10%

from 0.64

EPS Next Year

3.75

from 3.16

18.57%

from 3.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jan 31, 2020	Jan 31, 2021	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027
Revenue	531.99M	733.57M	756.56M	861.75M	999.59M	1.20B	1.32B	1.47B
Revenue Growth	85.21%	37.89%	3.13%	13.90%	16.00%	20.25%	9.73%	11.60%
EPS	0.58	0.12	-0.53	-0.31	0.64	3.16	3.75	4.60
EPS Growth	-50.43%	-79.48%	-	-	-	394.10%	18.57%	22.62%
Forward PE	-	-	-	-	-	30.26	25.52	20.81
No. Analysts	-	-	-	-	-	15	15	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.3B	1.4B	1.6B
Avg	1.2B	1.3B	1.5B
Low	1.2B	1.3B	1.4B

Revenue Growth

Revenue Growth	2025	2026	2027
High	26.0%	17.4%	21.7%
Avg	20.2%	9.7%	11.6%
Low	15.5%	4.5%	3.0%

EPS Forecast

EPS	2025	2026	2027
High	3.32	4.02	5.41
Avg	3.16	3.75	4.60
Low	3.01	3.53	4.17

EPS Growth

EPS Growth	2025	2026	2027
High	418.4%	27.2%	44.2%
Avg	394.1%	18.6%	22.6%
Low	370.1%	11.6%	11.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.